RHOA and cancer: RhoA is an oncogene that induces tumor progression through enhancing carcinogenic cell proliferation, angiogenesis, invasion and metastasis [21,147], suggesting the development of RhoA inhibitors could be a great strategy to restrain cancer promotion and progression [36].